Staging Hepatocellular Carcinoma by a Novel Scoring System (BALAD Score) Based on Serum Markers  Hidenori Toyoda, Takashi Kumada, Yukio Osaki, Hiroko.

Slides:



Advertisements
Similar presentations
Masatoshi Kudo  Clinical Gastroenterology and Hepatology 
Advertisements

The Role of Psychosocial Care in Adapting to Health Care Reform
A 30-Year, Population-Based Study Shows Improved Management and Prognosis of Hepatocellular Carcinoma  Boris Guiu, Anne Minello, Vanessa Cottet, Côme.
Real World Data of Daclatasvir and Asunaprevir Combination Therapy for HCV Genotype 1b Infection in Patients With Renal Dysfunction  Masatoshi Ishigami,
Abnormal Liver Tests and Fatty Liver on Ultrasound
Thrombocytopenia With Abnormal Liver Function Tests
Relationship Between Transferrin-Iron Saturation, Alcohol Consumption, and the Incidence of Cirrhosis and Liver Cancer  George N. Ioannou, Noel S. Weiss,
Level of α-Fetoprotein Predicts Mortality Among Patients With Hepatitis C–Related Hepatocellular Carcinoma  Gia L. Tyson, Zhigang Duan, Jennifer R. Kramer,
Presentation, Treatment, and Clinical Outcomes of Patients With Hepatocellular Carcinoma, With and Without Human Immunodeficiency Virus Infection  Adam.
Real World Data of Daclatasvir and Asunaprevir Combination Therapy for HCV Genotype 1b Infection in Patients With Renal Dysfunction  Masatoshi Ishigami,
Shou–Jiang Tang, Feriyl Bhaijee 
Gauree Gupta, Ebbing Lautenbach, James D. Lewis 
Katsunori Matsueda, Tatsuya Toyokawa 
Right Upper Quadrant Pain and a Normal Abdominal Ultrasound
Lauren A. Beste, George N. Ioannou, Yin Yang, Michael F
Amit G. Singal, Jasmin A. Tiro, Samir Gupta 
Stephen A. Harrison, MD, FACP  Clinical Gastroenterology and Hepatology 
Update on Biomarkers of Hepatocellular Carcinoma
Role of the GALAD and BALAD-2 Serologic Models in Diagnosis of Hepatocellular Carcinoma and Prediction of Survival in Patients  Sarah Berhane, Hidenori.
Leigh Ann White, Joseph Menzin, Jonathan R
Todd H. Baron, Patrick S. Kamath, Robert D. McBane 
Talya Salz, Robert S. Sandler  Clinical Gastroenterology and Hepatology 
Michel I. Kafrouni, Robert A. Anders, Sumita Verma 
Leon P. McLean, Jonathan S. Chun, Raymond K. Cross 
Obstructive Jaundice Caused by Intraductal Hepatocellular Carcinoma
Miho Sakumura, Kazuto Tajiri, Toshiro Sugiyama 
Abnormal Liver Tests and Fatty Liver on Ultrasound
William D. Leslie  Clinical Gastroenterology and Hepatology 
New Models of Gastroenterology Practice
Stephen J. Rulyak, David A. Lieberman, Edward H. Wagner, Margaret T
Issue Highlights Clinical Gastroenterology and Hepatology
The Glasgow Blatchford Score Is the Most Accurate Assessment of Patients With Upper Gastrointestinal Hemorrhage  Stig Borbjerg Laursen, Jane Møller Hansen,
Lance L. Stein, MD, Marty T. Sellers, MD, MPH 
Effects of Serum Aspartate Aminotransferase Levels in Patients With Autoimmune Hepatitis Influence Disease Course and Outcome  Thawab Al–Chalabi, James.
George N. Ioannou, Meaghan F. Splan, Noel S. Weiss, George B
An Asymptomatic, Radiographically Undetected Hepatocellular Carcinoma That Presented as a Large Retropancreatic Mass  Najat Mourra, Lionel Arrive, François.
Peter Richardson, Zhigang Duan, Jennifer Kramer, Jessica A
Amnon Sonnenberg  Clinical Gastroenterology and Hepatology 
Isolated Metastasis of Hepatocellular Carcinoma in the Right Ventricle
Development of Hepatocellular Carcinoma After Seroclearance of Hepatitis B Surface Antigen  Myron John Tong, Michael Ong Nguyen, Lori Terese Tong, Lawrence.
An Unusual Presentation of Hematemesis: A Presentation of Maxillary Metastasis From Hepatocellular Carcinoma  Ming–Jong Bair, Wei–Yi Lei, Chien–Lin Chen 
Cost Effectiveness of Alternative Surveillance Strategies for Hepatocellular Carcinoma in Patients With Cirrhosis  Karin L. Andersson, Joshua A. Salomon,
Patient-Reported Outcomes of Cirrhosis
A Young Woman With Gallstone Pancreatitis and Abnormal Liver Tests: When Is Endoscopic Retrograde Cholangiopancreatography Needed?  Andrew D. Rhim, Michael.
Colorectal Cancer Screening: How to Stop a Moving Target
Issue Highlights Clinical Gastroenterology and Hepatology
Effects of Different Coping Strategies on Physical and Mental Health of Patients With Irritable Bowel Syndrome  Lilian Dindo, PhD  Clinical Gastroenterology.
Mohamad H. Imam, Marina G. Silveira, Emmanouil Sinakos, Andrea A
Alan Bonder, MD, Nezam H. Afdhal, MD 
Thrombocytopenia With Abnormal Liver Function Tests
Issue Highlights Clinical Gastroenterology and Hepatology
Liver Transplantation for Hepatocellular Carcinoma
Hepatitis C Virus Infection, Age, and Hispanic Ethnicity Increase Mortality From Liver Cancer in the United States  Zobair M. Younossi, Maria Stepanova 
Rocco Ricciardi, Robert D. Madoff, David A. Rothenberger, Nancy N
Hematochezia From Metastasis of Hepatocellular Carcinoma to Colon in a Patient Who Underwent Liver Transplantation  Ruhail Kohli, Andrei S. Purysko, Binu.
A 27-Year-Old Woman With Constipation: Diagnosis and Treatment
Impact of Surveillance on Survival of Patients With Initial Hepatocellular Carcinoma: A Study From Japan  Hidenori Toyoda, Takashi Kumada, Seiki Kiriyama,
Coagulation in Liver Disease: A Guide for the Clinician
Issue Highlights Clinical Gastroenterology and Hepatology
Masatoshi Kudo  Clinical Gastroenterology and Hepatology 
Prognostic Significance of Simultaneous Measurement of Three Tumor Markers in Patients With Hepatocellular Carcinoma  Hidenori Toyoda, Takashi Kumada,
Black and White Liver Clinical Gastroenterology and Hepatology
Rintaro Hashimoto, Akimichi Chonan 
Adverse Outcomes: Why Bad Things Happen to Good People
A 30-Year, Population-Based Study Shows Improved Management and Prognosis of Hepatocellular Carcinoma  Boris Guiu, Anne Minello, Vanessa Cottet, Côme.
Issue Highlights Clinical Gastroenterology and Hepatology
Rintaro Hashimoto, Akimichi Chonan 
The Role of Psychosocial Care in Adapting to Health Care Reform
Incidence of Hepatocellular Carcinoma Among US Patients With Cirrhosis of Viral or Nonviral Etiologies  Robert D. Mair, Antonia Valenzuela, Nghiem B.
Choosing Wisely and the Perceived Drivers of Endoscopy Use
Presentation transcript:

Staging Hepatocellular Carcinoma by a Novel Scoring System (BALAD Score) Based on Serum Markers  Hidenori Toyoda, Takashi Kumada, Yukio Osaki, Hiroko Oka, Fumihiro Urano, Masatoshi Kudo, Takashi Matsunaga  Clinical Gastroenterology and Hepatology  Volume 4, Issue 12, Pages 1528-1536 (December 2006) DOI: 10.1016/j.cgh.2006.09.021 Copyright © 2006 AGA Institute Terms and Conditions

Figure 1 Distribution of patients with HCC according to tumor marker elevation. Cutoff values were set at 400 ng/mL for AFP, 15% for AFP-L3, and 100 mAU/mL for DCP. Clinical Gastroenterology and Hepatology 2006 4, 1528-1536DOI: (10.1016/j.cgh.2006.09.021) Copyright © 2006 AGA Institute Terms and Conditions

Figure 2 Patient survival according to the elevation of a tumor marker. (A) According to the elevation of AFP; (B) according to AFP-L3; (C) according to DCP. Patients with elevation of a tumor marker exhibited significantly lower survival rate in comparison with those without the elevation of tumor marker for all 3 markers. Clinical Gastroenterology and Hepatology 2006 4, 1528-1536DOI: (10.1016/j.cgh.2006.09.021) Copyright © 2006 AGA Institute Terms and Conditions

Figure 3 Patient survival according to tumor progression. (A) According to TNM tumor stage by Liver Cancer Study Group of Japan; (B) according to number of elevated tumor markers. Both systems predicted patient survival well, and the discriminative ability was comparable. Clinical Gastroenterology and Hepatology 2006 4, 1528-1536DOI: (10.1016/j.cgh.2006.09.021) Copyright © 2006 AGA Institute Terms and Conditions

Figure 4 Patient survival according to remnant liver function. (A) According to Child-Pugh classification; (B) according to serum bilirubin-albumin score. Both systems predicted patient survival well, and the discriminative ability was comparable. Clinical Gastroenterology and Hepatology 2006 4, 1528-1536DOI: (10.1016/j.cgh.2006.09.021) Copyright © 2006 AGA Institute Terms and Conditions

Figure 5 Patient survival according to previously reported staging systems. (A) According to CLIP scoring system; (B) according to JIS scoring system. Both systems predicted patient survival well. Clinical Gastroenterology and Hepatology 2006 4, 1528-1536DOI: (10.1016/j.cgh.2006.09.021) Copyright © 2006 AGA Institute Terms and Conditions

Figure 6 Patient survival according to BALAD scoring system. BALAD scores predicted patient survival well, and the discriminative ability was comparable to that of the CLIP and JIS systems. Clinical Gastroenterology and Hepatology 2006 4, 1528-1536DOI: (10.1016/j.cgh.2006.09.021) Copyright © 2006 AGA Institute Terms and Conditions